XERS Operating Cash Flow (Statement)
Xeris Biopharma Holdings Inc · Operating Cash Flow (Statement)
XERS Operating Cash Flow (Statement)
Latest reported$8.26Mperiod ending
XERS Quarterly Cash from Operations (-$3.52M → $8.26M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
XERS operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| 8,263,000 | |
| 9,870,000 | |
| 20,043,000 | |
| 18,432,000 | |
| 182,000 | |
| -10,031,000 | |
| 1,975,000 | |
| -8,305,000 | |
| -10,348,000 | |
| -20,303,000 | |
| 6,286,000 | |
| -14,610,000 | |
| -13,744,000 | |
| -26,140,000 | |
| -16,119,000 | |
| -17,754,000 | |
| -20,609,000 | |
| -48,409,000 | |
| -28,946,000 | |
| -22,611,000 | |
| -20,022,000 | |
| -23,956,000 | |
| -10,869,000 | |
| -16,985,000 | |
| -23,759,000 | |
| -28,945,000 | |
| -29,572,000 | |
| -30,583,000 | |
| -23,037,000 | |
| -21,154,000 | |
| -18,335,000 | |
| -15,917,000 | |
| -14,222,000 | |
| -7,805,000 | |
| -9,100,000 | |
| -5,577,000 | |
| -6,467,000 | |
| -3,519,000 |